chrX-139602462-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_001171876.2(MCF2):āc.2008A>Gā(p.Asn670Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00113 in 1,200,241 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 426 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.00087 ( 0 hom., 20 hem., cov: 23)
Exomes š: 0.0012 ( 0 hom. 406 hem. )
Consequence
MCF2
NM_001171876.2 missense
NM_001171876.2 missense
Scores
8
5
4
Clinical Significance
Conservation
PhyloP100: 7.91
Genes affected
MCF2 (HGNC:6940): (MCF.2 cell line derived transforming sequence) The oncogenic protein encoded by this gene is a guanine nucleotide exchange factor (GEF) that exerts control over some members of the Rho family of small GTPases. Several transcript variants encoding different isoforms have been found for this gene. These isoforms exhibit different expression patterns and varying levels of GEF activity.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0896844).
BP6
Variant X-139602462-T-C is Benign according to our data. Variant chrX-139602462-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 378121.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Hemizygotes in GnomAd4 at 20 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MCF2 | NM_001171876.2 | c.2008A>G | p.Asn670Asp | missense_variant | 20/29 | ENST00000519895.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MCF2 | ENST00000519895.6 | c.2008A>G | p.Asn670Asp | missense_variant | 20/29 | 2 | NM_001171876.2 | P4 |
Frequencies
GnomAD3 genomes AF: 0.000873 AC: 98AN: 112249Hom.: 0 Cov.: 23 AF XY: 0.000582 AC XY: 20AN XY: 34393
GnomAD3 genomes
AF:
AC:
98
AN:
112249
Hom.:
Cov.:
23
AF XY:
AC XY:
20
AN XY:
34393
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000826 AC: 145AN: 175452Hom.: 0 AF XY: 0.000793 AC XY: 48AN XY: 60562
GnomAD3 exomes
AF:
AC:
145
AN:
175452
Hom.:
AF XY:
AC XY:
48
AN XY:
60562
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00115 AC: 1255AN: 1087937Hom.: 0 Cov.: 26 AF XY: 0.00115 AC XY: 406AN XY: 353923
GnomAD4 exome
AF:
AC:
1255
AN:
1087937
Hom.:
Cov.:
26
AF XY:
AC XY:
406
AN XY:
353923
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000873 AC: 98AN: 112304Hom.: 0 Cov.: 23 AF XY: 0.000580 AC XY: 20AN XY: 34458
GnomAD4 genome
AF:
AC:
98
AN:
112304
Hom.:
Cov.:
23
AF XY:
AC XY:
20
AN XY:
34458
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
8
ALSPAC
AF:
AC:
6
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
11
ExAC
AF:
AC:
115
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 15, 2015 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 03, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.;.;T;.;.;.
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
.;M;.;.;.;.;M;.
MutationTaster
Benign
D;D;D;D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
.;D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Pathogenic
.;D;D;D;D;D;D;D
Sift4G
Pathogenic
.;D;D;D;D;D;D;D
Polyphen
0.53, 0.92, 0.18
.;P;.;.;.;.;P;B
Vest4
0.85, 0.83, 0.83, 0.83, 0.85
MVP
MPC
0.50
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at